Isolated Leprosy of Pinna Masquerading Perichondritis : A Rarest Entity

Paudel D¹, Sah BP^1, , Bhandary S¹, Shilpakar SL¹, Chettri ST¹ and Mishra S¹

¹Department of Otorhinolaryngology & Head and Neck Surgery, B. P. Koirala Institute of Health Sciences, Dharan, Sunsari, Nepal

Cite this paper:
Paudel D, Sah BP, Bhandary S, Shilpakar SL, Chettri ST and Mishra S. Isolated Leprosy of Pinna Masquerading Perichondritis : A Rarest Entity. American Journal of Medical Case Reports. 2014; 2(4):87-89. doi: 10.12691/ajmcr-2-4-5

Abstract

Leprosy is a chronic bacterial disease caused by Mycobacterium leprae. It is the oldest known disease to human beings. Incubation period ranges from weeks to years. The prevalence of leprosy varies markedly from country to country. However, the overwhelming majority of cases are found in developing countries and 92 percent of the cases are detected in just 11 countries led by India and Brazil. Grossly leprosy is divided into lepromatous and tubercular form, based on immunological pattern of disease. Though leprosy is common condition, isolated leprosy of pinna has not been reported so far in the literature. We report a male of 15 years with clinical feature of perichondritis of left pinna due to leprosy.

Keywords:
leprosy perichondritis pinna

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Britton, W.J., Lockwood, D.N., Leprosy, Lancet, 363(9416), 1209-19, 2004.
[2]	Moschella, S.L., An update on the diagnosis and treatment of leprosy, J Am Acad Dermatol, 51(3), 4176-2, 2004.
[3]	Gupta, S., Mehta, A., Lakhtakia, R., Nema, S.K.,` An unusual presentation of lepromatous leprosy. MJAFI, 62,392-93, 2006.
[4]	Leprosy: global situation [Editorial], Wkly Epidemiol Rec, 75(28), 226-31, 2000.
[5]	Sapkota, B.R., Ranjit, C., Neupane, K.D., Macdonald, M., Development and evaluation of a novel multiple-primer PCR amplification refractory mutation system for the rapid detection of mutations conferring rifampicin resistance in codon 425 of the rpoB gene of Mycobacterium leprae, J Med Microbiol, 57(Pt 2), 179-84, 2008.
[6]	Job, C.K., Pathology of leprosy. In: Hastings RS, Opromolla DVA, editors. Leprosy, 2nd ed, Philadelphia, Churchill Livingstone, 190-233, 1994.
[7]	WHO Expert Committee on Leprosy, 7th Report (WHO Technical Report Series, No.874), Geneva: World Health Organization, 1998
[8]	Global Strategy for Further Reducing the Leprosy Burden and Sustaining Leprosy Control Activities 2006-2010 Operational Guidelines, World Health Organization, 21, 2006.
[9]	Negrao, F.R., Duerksen, F., Emergency in leprosy: involvement of the larynx, Leprosy Rev, 78(2), 148-50, 2007.